Karius, Inc.

Karius, Inc.

Karius, Inc.

Karius is focused on conquering infectious diseases. 1250+ pathogens detected from a single blood draw using NGS. CLIA-licensed and CAP Accredited.
Type
B2b
Founded
2014
Raised
$240M
Follow us
Alexa global traffic share
Twitter followers
24 Feb 2020

Karius Raises $165M In Series B Funding

FinSMEs
+1
05 Aug 2017
$50,000,000
Venture capital (Series A)

Karius Raises $50M in Series A Financing

GenomeWeb
+4